Athe Tsibris
Head of the HIV Eradication and Latency (HEAL) Cohort · Brigham
Credentials: · · · ·
History
- Present
HIV Eradication and Latency (HEAL) cohort Division · Brigham
- Present
- 2003–2005
Massachusetts General Hospital and Brigham and Women’s Hospital
- 1998–2001
Internal Medicine
- 1998–1999
Research
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Nature Communications · 2020 · 698 citations
Determination of RNA structural diversity and its role in HIV-1 RNA splicing
Nature · 2020 · 194 citations
PLoS ONE · 2009 · First of 17 authors · 181 citations
24 papers
8 papers · 1 as a fellow
6 papers
6 papers · 3 as a fellow
- CF
5 papers
- EC
4 papers
4 papers
4 papers
Grants
- 2004–2029
Harvard University Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $2.6M · Harvard University
- 2026–2027
Intrinsic CD4? T Cell Barriers to HIV-1 Latency Reversal
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $895K · Brigham and Women's Hospital
- 2022–2027
High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir
National Institute of Allergy and Infectious Diseases · P01
PI · $8.5M · Brigham and Women's Hospital
- 2021–2026
HIV-2 Latency and Its Reversal
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $4.6M · Brigham and Women's Hospital
Clinical trials
- 2019–2022
Pharmacokinetics and Safety of SAR441236
Study chair · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)